SFX by Ex Libris Inc.

Title:	Cell Penetrant Inhibitors of the KDM4 and KDM5 Families of Histone Lysine Demethylases. 2. Pyrido[3,4-d]pyrimidin-4(3H)-one Derivatives
Source:	Journal of Medicinal Chemistry [0022-2623] yr:2016

Basic

Full text

Full text available via American Chemical Society Journals

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Korczynska, M. "Docking and Linking of Fragments To Discover Jumonji Histone Demethylase Inhibitors." Journal of medicinal chemistry 59.4 (2016): 1580-1598.
description	2.	Lienlaf, M. "Essential role of HDAC6 in the regulation of PD-L1 in melanoma." Molecular Oncology 10.5 (2016): 735-750.
description	3.	Bavetsias, V. "8-Substituted Pyrido[3,4-d]pyrimidin-4(3H)-one Derivatives As Potent, Cell Permeable, KDM4 (JMJD2) and KDM5 (JARID1) Histone Lysine Demethylase Inhibitors." Journal of medicinal chemistry 59.4 (2016): 1388-1409.
description	4.	Liu, X. "The Histone Demethylase KDM5 Activates Gene Expression by Recognizing Chromatin Context through Its PHD Reader Motif." Cell Reports 13.10 (2015): 2219-31.
description	5.	Maes, T. "Advances in the development of histone lysine demethylase inhibitors." Current opinion in pharmacology 23.1 (2015): 52-60.
description	6.	Maecker, Holden T T. "Flow cytometry controls, instrument setup, and the determination of positivity." Cytometry Part A 69.9 (2006): 1037-42.
description	7.	Feng, T. "Novel 5-carboxy-8-HQ based histone demethylase JMJD2A inhibitors: Introduction of an additional carboxyl group at the C-2 position of quinoline." European journal of medicinal chemistry 105 (2015): 145-155.
description	8.	Duan, L. "KDM4/JMJD2 Histone Demethylase Inhibitors Block Prostate Tumor Growth by Suppressing the Expression of AR and BMYB-Regulated Genes." Chemistry & biology 22.9 (2015): 1185-1196.
description	9.	Gustin, Darin J. "Identification of potent, noncovalent fatty acid amide hydrolase (FAAH) inhibitors." Bioorganic and medicinal chemistry letters 21.8 (2011): 2492-2496.
description	10.	Vinogradova, M. "An inhibitor of KDM5 demethylases reduces survival of drug-tolerant cancer cells." Nature Chemical Biology 12.7 (2016): 531-538.
description	11.	Ariffin, Juliana K. "Histone Deacetylase Inhibitors Promote Mitochondrial Reactive Oxygen Species Production and Bacterial Clearance by Human Macrophages." Antimicrobial agents and chemotherapy 60.3 (2016): 1521-1529.
description	12.	Chao, M. "The synergic effect of vincristine and vorinostat in leukemia in vitro and in vivo." Journal of Hematology & Oncology 8.1 (2015): 1-15.
description	13.	Doench, David G. "Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9." Nature Biotechnology 34.2 (2016): 184-191.
description	14.	Woan, K. "Targeting histone deacetylase 6 mediates a dual anti-melanoma effect: Enhanced antitumor immunity and impaired cell proliferation." Molecular Oncology 9.7 (2015): 1447-1457.
description	15.	Pieroni, M. "Further insights into the SAR of α-substituted cyclopropylamine derivatives as inhibitors of histone demethylase KDM1A." European journal of medicinal chemistry 92 (2015): 377-386.
description	16.	Huang, Y. "Histone demethylase KDM2A promotes tumor cell growth and migration in gastric cancer." Tumor biology 36.1 (2014): 271-8.
description	17.	Huberfeld, G. "Tumoral epileptogenicity: How does it happen?" Epilepsia 54 Suppl 9.s9 (2013): 30-34.
description	18.	Saha, B. "EED and KDM6B coordinate the first mammalian cell lineage commitment to ensure embryo implantation." Molecular and cellular biology 33.14 (2013): 2691-2705.
description	19.	Herzenberg, David R A. "Interpreting flow cytometry data: a guide for the perplexed." Nature immunology 7.7 (2006): 681-685.
description	20.	Hendel, A. "Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells." Nature biotechnology 33.9 (2015): 985-9.